DAIC

APRIL 11, 2024

The study, called IVUS-DCB, is the first randomized controlled trial to demonstrate the clinical benefits of using IVUS in angioplasty procedures for peripheral artery disease (PAD), a condition in which plaque builds up in arteries in the legs. The study was funded by Medtronic, Inc. and Korea United Pharm.

Peripheral Arterial Disease 116

Peripheral Arterial Disease Ultrasound Angioplasty Plaque 116

DAIC

JUNE 4, 2024

a vascular surgeon and director of HonorHealth’s vascular services, said the device avoids carotid endarterectomy, a previous method for removing plaque from carotid arteries, which involves a surgical procedure requiring an incision directly into the neck. who has suffered from peripheral artery disease for years.

Stent 111

Stent Stents Research Stroke 111

DAIC

NOVEMBER 8, 2024

tim.hodson Fri, 11/08/2024 - 10:10 Medtronic recently announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions. Results from both analyses were released at the Vascular InterVentional Advances (VIVA) 2024 conference in Las Vegas. DA+DCB versus 5.9%

Stents 52

Stents Stent Angioplasty Peripheral Arterial Disease 52

DAIC

JULY 11, 2024

a Mountain View, CA-based developer of novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), has announced the appointment of Josh Smale as its Vice President of Global Clinical and Scientific Affairs. Medical device company R3 Vascular Inc., Image courtesy: R3 Vascular Inc.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Stents Stent Education 105

DAIC

MAY 30, 2024

milla1cf Thu, 05/30/2024 - 10:14 May 30, 2024 — B iotronik announced the presentation of the 12-month results from the BIONETIC-I study this week at LINC 2024. BIOTRONIK Dynetic-35 cobalt chromium balloon-expandable stent for peripheral iliac lesions: 12-month results of the BIONETIC-I Multi-Center study.

Stent 69

Stent Stents Peripheral Arterial Disease Innovation 69

DAIC

FEBRUARY 14, 2024

Encouraged by the early clinical results, Efemoral Medical is now developing an additional device for treating below-the-knee (infrapopliteal) arteries in patients with CLTI. Diseased human arteries are most simply, reliably, and successfully treated with drug-eluting, balloon-expandable stents," said Lewis B.

Heart attacks 111

Heart attacks Heart Attack Peripheral Arterial Disease Ischemia 111

DAIC

JUNE 18, 2024

The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. 1 To date, interventional treatment of coronary artery disease with drug-eluting stents has been able to establish flow angiographically. of the U.S.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105